G Bonadonna|P Valagussa - JoVE Visualize

Showing results (81-90 of 263) with videos related to

Pageof 27

Sort By:

Breast Cancer Research and Treatment|June 16, 1999

Comparative analysis of breast cancer recurrence risk for patients receiving or not receiving adjuvant cyclophosphamide, methotrexate, fluorouracil (CMF). Data supporting the occurrence of 'cures'R Demicheli, R Miceli, C Brambilla, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1990

3H-thymidine-labeling index as a prognostic indicator in node-positive breast cancerR Silvestrini, M G Daidone, P Valagussa, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1991

Testicular dysfunction in Hodgkin's disease before and after treatmentS Viviani, G Ragni, A Santoro, et al.

Cancer Clinical Trials|January 1, 1981

Multimodal treatment for locally advanced breast cancer. Result of chemotherapy-radiotherapy versus chemotherapy-surgeryM De Lena, M Varini, R Zucali, et al.

British Medical Journal|January 26, 1980

Second malignancies in Hodgkin's disease: a complication of certain forms of treatmentP Valagussa, A Santoro, R Kenda, et al.

Journal of the National Cancer Institute. Monographs|January 1, 1992

Adjuvant CMF for node-negative and estrogen receptor-negative breast cancer patientsM Zambetti, G Bonadonna, P Valagussa, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2000

Fludarabine and cladribine in relapsed/refractory low-grade non-Hodgkin's lymphoma: a phase II randomized studyC Tondini, M Balzarotti, I Rampinelli, et al.

Clinical & Experimental Metastasis|April 1, 1983

T3b-T4 breast cancer: factors affecting results in combined modality treatmentsP Valagussa, M Zambetti, P Bignami, et al.

Tumori|April 30, 1983

Non-Hodgkin's lymphomas of Waldeyer's ringE Bajetta, R Buzzoni, F Rilke, et al.

American Journal of Clinical Oncology|October 1, 1987

Comparison of different trials of adjuvant chemotherapy in stage II breast cancer using a natural history data baseS E Jones, T E Moon, G Bonadonna, et al.

Pageof 27

Showing results (81-90 of 263) with videos related to

Sort By:

Pageof 27

Breast Cancer Research and Treatment|June 16, 1999

Comparative analysis of breast cancer recurrence risk for patients receiving or not receiving adjuvant cyclophosphamide, methotrexate, fluorouracil (CMF). Data supporting the occurrence of 'cures'R Demicheli, R Miceli, C Brambilla, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1990

3H-thymidine-labeling index as a prognostic indicator in node-positive breast cancerR Silvestrini, M G Daidone, P Valagussa, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1991

Testicular dysfunction in Hodgkin's disease before and after treatmentS Viviani, G Ragni, A Santoro, et al.

Cancer Clinical Trials|January 1, 1981

Multimodal treatment for locally advanced breast cancer. Result of chemotherapy-radiotherapy versus chemotherapy-surgeryM De Lena, M Varini, R Zucali, et al.

British Medical Journal|January 26, 1980

Second malignancies in Hodgkin's disease: a complication of certain forms of treatmentP Valagussa, A Santoro, R Kenda, et al.

Journal of the National Cancer Institute. Monographs|January 1, 1992

Adjuvant CMF for node-negative and estrogen receptor-negative breast cancer patientsM Zambetti, G Bonadonna, P Valagussa, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2000

Fludarabine and cladribine in relapsed/refractory low-grade non-Hodgkin's lymphoma: a phase II randomized studyC Tondini, M Balzarotti, I Rampinelli, et al.

Clinical & Experimental Metastasis|April 1, 1983

T3b-T4 breast cancer: factors affecting results in combined modality treatmentsP Valagussa, M Zambetti, P Bignami, et al.

Tumori|April 30, 1983

Non-Hodgkin's lymphomas of Waldeyer's ringE Bajetta, R Buzzoni, F Rilke, et al.

American Journal of Clinical Oncology|October 1, 1987

Comparison of different trials of adjuvant chemotherapy in stage II breast cancer using a natural history data baseS E Jones, T E Moon, G Bonadonna, et al.

Pageof 27